{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:32:03Z","timestamp":1773293523857,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T00:00:00Z","timestamp":1336608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10534-012-9553-7","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T08:26:19Z","timestamp":1336551979000},"page":"815-824","source":"Crossref","is-referenced-by-count":8,"title":["Synaptic defects associated with s-inclusion body myositis are prevented by copper"],"prefix":"10.1007","volume":"25","author":[{"given":"R.","family":"Aldunate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. N.","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rebolledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. C.","family":"Inestrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,10]]},"reference":[{"key":"9553_CR1","first-page":"213","volume":"90","author":"RD Adams","year":"1965","unstructured":"Adams RD, Kakulas BA, Samaha FA (1965) A myopathy with cellular inclusions. Trans Am Neurol Assoc 90:213\u2013216","journal-title":"Trans Am Neurol Assoc"},{"key":"9553_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/60.1.1","volume":"60","author":"V Askanas","year":"2001","unstructured":"Askanas V, Engel WK (2001) Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J Neuropathol Exp Neurol 60:1\u201314","journal-title":"J Neuropathol Exp Neurol"},{"key":"9553_CR3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00019052-200210000-00002","volume":"15","author":"V Askanas","year":"2002","unstructured":"Askanas V, Engel WK (2002) Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms. Curr Opin Neurol 15:525\u2013531","journal-title":"Curr Opin Neurol"},{"key":"9553_CR4","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/01.wnl.0000192128.13875.1e","volume":"66","author":"V Askanas","year":"2006","unstructured":"Askanas V, Engel WK (2006) Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 66:S39\u2013S48","journal-title":"Neurology"},{"key":"9553_CR5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/BOR.0b013e3282efdc7c","volume":"19","author":"V Askanas","year":"2007","unstructured":"Askanas V, Engel WK (2007) Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr Opin Rheumatol 19:550\u2013559","journal-title":"Curr Opin Rheumatol"},{"key":"9553_CR6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-008-0449-0","volume":"116","author":"V Askanas","year":"2008","unstructured":"Askanas V, Engel WK (2008) Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer\u2019s and Parkinson\u2019s disease brains. Acta Neuropathol 116:583\u2013595","journal-title":"Acta Neuropathol"},{"key":"9553_CR7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410340408","volume":"34","author":"V Askanas","year":"1993","unstructured":"Askanas V, Alvarez RB, Engel WK (1993) Beta-amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol 34:551\u2013560","journal-title":"Ann Neurol"},{"key":"9553_CR8","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1073\/pnas.2332818100","volume":"100","author":"TA Bayer","year":"2003","unstructured":"Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, Tepest R, Eckert A, Schussel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, Multhaup G (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci USA 100:14187\u201314192","journal-title":"Proc Natl Acad Sci USA"},{"key":"9553_CR9","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.M400805200","volume":"279","author":"SA Bellingham","year":"2004","unstructured":"Bellingham SA, Lahiri DK, Maloney B, La Fontaine S, Multhaup G, Camakaris J (2004) Copper depletion down-regulates expression of the Alzheimer\u2019s disease amyloid-beta precursor protein gene. J Biol Chem 279:20378\u201320386","journal-title":"J Biol Chem"},{"key":"9553_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","volume":"77","author":"S Brenner","year":"1974","unstructured":"Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71\u201394","journal-title":"Genetics"},{"key":"9553_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/pr.108.000562","volume":"61","author":"SD Buckingham","year":"2009","unstructured":"Buckingham SD, Jones AK, Brown LA, Sattelle DB (2009) Nicotinic acetylcholine receptor signalling: roles in Alzheimer\u2019s disease and amyloid neuroprotection. Pharmacol Rev 61:39\u201361","journal-title":"Pharmacol Rev"},{"key":"9553_CR12","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1016\/S0021-9258(17)32694-7","volume":"269","author":"AI Bush","year":"1994","unstructured":"Bush AI, Pettingell WH Jr, Paradis MD, Tanzi RE (1994a) Modulation of A beta adhesiveness and secretase site cleavage by zinc. J Biol Chem 269:12152\u201312158","journal-title":"J Biol Chem"},{"key":"9553_CR13","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.8073293","volume":"265","author":"AI Bush","year":"1994","unstructured":"Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL, Tanzi RE (1994b) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265:1464\u20131467","journal-title":"Science"},{"key":"9553_CR14","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1073\/pnas.2135061100","volume":"100","author":"AI Bush","year":"2003","unstructured":"Bush AI, Masters CL, Tanzi RE (2003) Copper, beta-amyloid, and Alzheimer\u2019s disease: tapping a sensitive connection. Proc Natl Acad Sci USA 100:11193\u201311194","journal-title":"Proc Natl Acad Sci USA"},{"key":"9553_CR15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1096\/fj.03-1349fje","volume":"18","author":"WF Cerpa","year":"2004","unstructured":"Cerpa WF, Barria MI, Chacon MA, Suazo M, Gonzalez M, Opazo C, Bush AI, Inestrosa NC (2004) The N-terminal copper-binding domain of the amyloid precursor protein protects against Cu2+ neurotoxicity in vivo. FASEB J 18:1701\u20131703","journal-title":"FASEB J"},{"key":"9553_CR16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.mam.2005.07.011","volume":"26","author":"W Cerpa","year":"2005","unstructured":"Cerpa W, Varela-Nallar L, Reyes AE, Minniti AN, Inestrosa NC (2005) Is there a role for copper in neurodegenerative diseases? Mol Aspects Med 26:405\u2013420","journal-title":"Mol Aspects Med"},{"key":"9553_CR17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron 30:665\u2013676","journal-title":"Neuron"},{"key":"9553_CR18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2174\/138161206775474224","volume":"12","author":"MR D\u2019Andrea","year":"2006","unstructured":"D\u2019Andrea MR, Nagele RG (2006) Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer\u2019s disease pyramidal neurons. Curr Pharm Des 12:677\u2013684","journal-title":"Curr Pharm Des"},{"key":"9553_CR19","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FG Felice De","year":"2007","unstructured":"De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an N-Methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590\u201311601","journal-title":"J Biol Chem"},{"key":"9553_CR20","doi-asserted-by":"crossref","first-page":"25056","DOI":"10.1074\/jbc.M200066200","volume":"277","author":"KT Dineley","year":"2002","unstructured":"Dineley KT, Bell KA, Bui D, Sweatt JD (2002) Beta-amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 277:25056\u201325061","journal-title":"J Biol Chem"},{"key":"9553_CR21","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1046\/j.1471-4159.1998.71041616.x","volume":"71","author":"DS Fay","year":"1998","unstructured":"Fay DS, Fluet A, Johnson CJ, Link CD (1998) In vivo aggregation of beta-amyloid peptide variants. J Neurochem 71:1616\u20131625","journal-title":"J Neurochem"},{"key":"9553_CR22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuron.2005.04.010","volume":"46","author":"MM Francis","year":"2005","unstructured":"Francis MM, Evans SP, Jensen M, Madsen DM, Mancuso J, Norman KR, Maricq AV (2005) The Ror receptor tyrosine kinase CAM-1 is required for ACR-16-mediated synaptic transmission at the C. elegans neuromuscular junction. Neuron 46:581\u2013594","journal-title":"Neuron"},{"key":"9553_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ymeth.2010.12.036","volume":"53","author":"AJ Harrington","year":"2011","unstructured":"Harrington AJ, Knight AL, Caldwell GA, Caldwell KA (2011) Caenorhabditis elegans as a model system for identifying effectors of alpha-synuclein misfolding and dopaminergic cell death associated with Parkinson\u2019s disease. Methods 53:220\u2013225","journal-title":"Methods"},{"key":"9553_CR24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/15216540500264620","volume":"57","author":"NC Inestrosa","year":"2005","unstructured":"Inestrosa NC, Cerpa W, Varela-Nallar L (2005) Copper brain homeostasis: role of amyloid precursor protein and prion protein. IUBMB Life 57:645\u2013650","journal-title":"IUBMB Life"},{"key":"9553_CR25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00115-004-1849-6","volume":"76","author":"H Kessler","year":"2005","unstructured":"Kessler H, Pajonk FG, Supprian T, Falkai P, Multhaup G, Bayer TA (2005) The role of copper in the pathophysiology of Alzheimer\u2019s disease. Nervenarzt 76:581\u2013585","journal-title":"Nervenarzt"},{"key":"9553_CR26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J Neurosci 27:796\u2013807","journal-title":"J Neurosci"},{"key":"9553_CR27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer\u2019s disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 11:170\u2013176","journal-title":"Trends Mol Med"},{"key":"9553_CR28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM LaFerla","year":"2007","unstructured":"LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer\u2019s disease. Nat Rev Neurosci 8:499\u2013509","journal-title":"Nat Rev Neurosci"},{"key":"9553_CR29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352\u2013357","journal-title":"Nature"},{"key":"9553_CR30","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.1073\/pnas.92.20.9368","volume":"92","author":"CD Link","year":"1995","unstructured":"Link CD (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 92:9368\u20139372","journal-title":"Proc Natl Acad Sci USA"},{"key":"9553_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1601-183X.2004.00105.x","volume":"4","author":"CD Link","year":"2005","unstructured":"Link CD (2005) Invertebrate models of Alzheimer\u2019s disease. Genes Brain Behav 4:147\u2013156","journal-title":"Genes Brain Behav"},{"key":"9553_CR32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0197-4580(00)00237-2","volume":"22","author":"CD Link","year":"2001","unstructured":"Link CD, Johnson CJ, Fonte V, Paupard M, Hall DH, Styren S, Mathis CA, Klunk WE (2001) Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol Aging 22:217\u2013226","journal-title":"Neurobiol Aging"},{"issue":"Pt 3","key":"9553_CR33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/112.3.727","volume":"112","author":"BP Lotz","year":"1989","unstructured":"Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ (1989) Inclusion body myositis. Observations in 40 patients. Brain 112(Pt 3):727\u2013747","journal-title":"Brain"},{"key":"9553_CR34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","volume":"56","author":"E Masliah","year":"2001","unstructured":"Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW Jr, Morris JC (2001a) Altered expression of synaptic proteins occurs early during progression of Alzheimer\u2019s disease. Neurology 56:127\u2013129","journal-title":"Neurology"},{"key":"9553_CR35","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1097\/00001756-200112210-00009","volume":"12","author":"E Masliah","year":"2001","unstructured":"Masliah E, Alford M, Galasko D, Salmon D, Hansen LA, Good PF, Perl DP, Thal L (2001b) Cholinergic deficits in the brains of patients with parkinsonism-dementia complex of Guam. Neuroreport 12:3901\u20133903","journal-title":"Neuroreport"},{"key":"9553_CR36","doi-asserted-by":"crossref","first-page":"22697","DOI":"10.1074\/jbc.C109.028514","volume":"284","author":"G McColl","year":"2009","unstructured":"McColl G, Roberts BR, Gunn AP, Perez KA, Tew DJ, Masters CL, Barnham KJ, Cherny RA, Bush AI (2009) The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42. J Biol Chem 284:22697\u201322702","journal-title":"J Biol Chem"},{"key":"9553_CR37","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1097\/00001756-199810050-00013","volume":"9","author":"J McFerrin","year":"1998","unstructured":"McFerrin J, Engel WK, Askanas V (1998) Impaired innervation of cultured human muscle overexpressing betaAPP experimentally and genetically: relevance to inclusion-body myopathies. Neuroreport 9:3201\u20133205","journal-title":"Neuroreport"},{"key":"9553_CR38","doi-asserted-by":"crossref","first-page":"12593","DOI":"10.1073\/pnas.93.22.12593","volume":"93","author":"KG Miller","year":"1996","unstructured":"Miller KG, Alfonso A, Nguyen M, Crowell JA, Johnson CD, Rand JB (1996) A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc Natl Acad Sci USA 93:12593\u201312598","journal-title":"Proc Natl Acad Sci USA"},{"key":"9553_CR39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-4-2","volume":"4","author":"AN Minniti","year":"2009","unstructured":"Minniti AN, Rebolledo DL, Grez PM, Fadic R, Aldunate R, Volitakis I, Cherny RA, Opazo C, Masters C, Bush AI, Inestrosa NC (2009) Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification. Mol Neurodegener 4:2","journal-title":"Mol Neurodegener"},{"key":"9553_CR40","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20:4050\u20134058","journal-title":"J Neurosci"},{"key":"9553_CR41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0306-4522(01)00460-2","volume":"110","author":"RG Nagele","year":"2002","unstructured":"Nagele RG, D\u2019Andrea MR, Anderson WJ, Wang HY (2002) Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer\u2019s disease. Neuroscience 110:199\u2013211","journal-title":"Neuroscience"},{"key":"9553_CR42","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/jnnp.50.6.806","volume":"50","author":"EK Perry","year":"1987","unstructured":"Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G (1987) Nicotinic receptor abnormalities in Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurol Neurosurg Psychiatry 50:806\u2013809","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9553_CR43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4522(94)00410-7","volume":"64","author":"EK Perry","year":"1995","unstructured":"Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH (1995) Alteration in nicotine binding sites in Parkinson\u2019s disease, Lewy body dementia and Alzheimer\u2019s disease: possible index of early neuropathology. Neuroscience 64:385\u2013395","journal-title":"Neuroscience"},{"key":"9553_CR44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12035-008-8041-0","volume":"38","author":"DL Rebolledo","year":"2008","unstructured":"Rebolledo DL, Minniti AN, Grez PM, Fadic R, Kohn R, Inestrosa NC (2008) Inclusion body myositis: a view from the Caenorhabditis elegans muscle. Mol Neurobiol 38:178\u2013198","journal-title":"Mol Neurobiol"},{"key":"9553_CR45","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1523\/JNEUROSCI.0336-11.2011","volume":"31","author":"DL Rebolledo","year":"2011","unstructured":"Rebolledo DL, Aldunate R, Kohn R, Neira I, Minniti AN, Inestrosa NC (2011) Copper reduces Abeta oligomeric species and ameliorates neuromuscular synaptic defects in a C. elegans model of inclusion body myositis. J Neurosci 31:10149\u201310158","journal-title":"J Neurosci"},{"key":"9553_CR46","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60:1685\u20131691","journal-title":"Arch Neurol"},{"key":"9553_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10158-005-0014-7","volume":"6","author":"DB Sattelle","year":"2006","unstructured":"Sattelle DB, Buckingham SD (2006) Invertebrate studies and their ongoing contributions to neuroscience. Invert Neurosci 6:1\u20133","journal-title":"Invert Neurosci"},{"key":"9553_CR48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298:789\u2013791","journal-title":"Science"},{"key":"9553_CR49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0361-9230(01)00454-3","volume":"55","author":"D Strausak","year":"2001","unstructured":"Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G (2001) Copper in disorders with neurological symptoms: Alzheimer\u2019s, Menkes, and Wilson diseases. Brain Res Bull 55:175\u2013185","journal-title":"Brain Res Bull"},{"key":"9553_CR50","unstructured":"Toledo EM, Inestrosa NC (2009) Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer\u2019s disease. Mol Psychiatry 15:272\u2013285, 228"},{"key":"9553_CR51","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1046\/j.1471-4159.2000.0751155.x","volume":"75","author":"HY Wang","year":"2000","unstructured":"Wang HY, Lee DH, Davis CB, Shank RP (2000a) Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 75:1155\u20131161","journal-title":"J Neurochem"},{"key":"9553_CR52","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","volume":"275","author":"HY Wang","year":"2000","unstructured":"Wang HY, Lee DH, D\u2019Andrea MR, Peterson PA, Shank RP, Reitz AB (2000b) Beta-amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer\u2019s disease pathology. J Biol Chem 275:5626\u20135632","journal-title":"J Biol Chem"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-012-9553-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10534-012-9553-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-012-9553-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T06:47:19Z","timestamp":1642229239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10534-012-9553-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["9553"],"URL":"https:\/\/doi.org\/10.1007\/s10534-012-9553-7","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,10]]}}}